Conivaptan hydrochloride
- Level
- Commodity
- Parent
- 51182100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51182107This classification denotes a vasopressin antagonist with the molecular formula C32H26N4O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 75L57R6X36, chemically known as (1,1-biphenyl)-2-carboxamide, n-(4-(4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1h)-yl)carbonyl)phenyl)- but more generally known as conivaptan hydrochloride, which bears US NIH Compound Identifier 151171. Most nations, for tariff and trade purposes, schedule conivaptan hydrochloride under HS 29339930 and SITC 51577. As of Q4 2014, CONIVAPTAN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Conivaptan hydrochloride bears US NLM identifiers UMLS ID C1700196 and NCI Concept Code C65351. SMILES: CC1[NH]C-2C(N1)CCN(C3C2CCCC3)C(=O)C4CCC(CC4)NC(=O)C5CCCCC5C6CCCCC6.CL.
Same parent
Under 51182100 · 10Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.